Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;235(12):9110-9120.
doi: 10.1002/jcp.29776. Epub 2020 May 26.

The role of HSP90 molecular chaperones in hepatocellular carcinoma

Affiliations
Review

The role of HSP90 molecular chaperones in hepatocellular carcinoma

Masoud Nouri-Vaskeh et al. J Cell Physiol. 2020 Dec.

Abstract

Misfolded proteins have enhanced formation of toxic oligomers and nonfunctional protein copies lead to recruiting wild-type protein types. Heat shock protein 90 (HSP90) is a molecular chaperone generated by cells that are involved in many cellular functions through regulation of folding and/or localization of large multi-protein complexes as well as client proteins. HSP90 can regulate a number of different cellular processes including cell proliferation, motility, angiogenesis, signal transduction, and adaptation to stress. HSP90 makes the mutated oncoproteins able to avoid misfolding and degradation and permits the malignant transformation. As a result, HSP90 is an important factor in several signaling pathways associated with tumorigenicity, therapy resistance, and inhibiting apoptosis. Clinically, the upregulation of HSP90 expression in hepatocellular carcinoma (HCC) is linked with advanced stages and inappropriate survival in cases suffering from this kind of cancer. The present review comprehensively assesses HSP90 functions and its possible usefulness as a potential diagnostic biomarker and therapeutic option for HCC.

Keywords: chaperone proteins; heat shock protein 90; hepatocellular carcinoma; liver cancer.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Albrethsen, J., Miller, L. M., Novikoff, P. M., & Angeletti, R. H. (2011). Gel-based proteomics of liver cancer progression in rat. Biochimica et Biophysica Acta-Proteins Proteomics, 1814, 1367-1376. https://doi.org/10.1016/j.bbapap.2011.05.018
    1. Alexiou, G. A., Vartholomatos, G., Stefanaki, K., Patereli, A., Dova, L., Karamoutsios, A., … Prodromou, N. (2013). Expression of heat shock proteins in medulloblastoma. Journal of Neurosurgery Pediatrics, 12, 452-457. https://doi.org/10.3171/2013.7.peds1376
    1. Augello, G., Emma, M. R., Cusimano, A., Azzolina, A., Mongiovì, S., Puleio, R., … Cervello, M. (2019). Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma. International Journal of Cancer, 144, 2613-2624. https://doi.org/10.1002/ijc.31963
    1. Banz, V. M., Medová, M., Keogh, A., Furer, C., Zimmer, Y., Candinas, D., & Stroka, D. (2009). Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3β. Biochimica et Biophysica Acta-Molecular Cell Research, 1793, 1597-1603. https://doi.org/10.1016/j.bbamcr.2009.08.002
    1. Barrott, J. J., & Haystead, T. A. J. (2013). Hsp90, an unlikely ally in the war on cancer. FEBS Journal, 280, 1381-1396. https://doi.org/10.1111/febs.12147

Publication types

MeSH terms

Substances

LinkOut - more resources